Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Cash from Operations: 2021-2024

Historic Cash from Operations for biote (BTMD) over the last 4 years, with FY2024 value amounting to $45.2 million.

  • biote's Cash from Operations fell 953.97% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.1 million, marking a year-over-year decrease of 1529.31%. This contributed to the annual value of $45.2 million for FY2024, which is 6829.59% up from last year.
  • According to the latest figures from FY2024, biote's Cash from Operations is $45.2 million, which was up 6829.59% from $26.9 million recorded in FY2023.
  • In the past 5 years, biote's Cash from Operations ranged from a high of $45.2 million in FY2024 and a low of -$9.2 million during FY2022
  • Over the past 4 years, biote's median Cash from Operations value was $30.3 million (recorded in 2021), while the average stood at $24.2 million.
  • Per our database at Business Quant, biote's Cash from Operations crashed by 12715.6% in 2022 and then soared by 39357.87% in 2023.
  • Annual analysis of 4 years shows biote's Cash from Operations stood at $33.7 million in 2021, then tumbled by 127.16% to -$9.2 million in 2022, then soared by 393.58% to $26.9 million in 2023, then soared by 68.3% to $45.2 million in 2024.
  • Its Cash from Operations was $45.2 million in FY2024, compared to $26.9 million in FY2023 and -$9.2 million in FY2022.